| Event |
Proneuron's Activities / Presentations |
American Spinal Injury Association
conference
14-16 May 2004
The Westin Tabor Center
Denver |
- An open label study of autologous incubated macrophages in patients
with acute complete spinal injury -
Abstract
- Activated Autologous Macrophages Therapy for Spinal Cord Injury:
characterization of the cellular phenotype -
Abstract
|
RALLY FOR THE CURE
(www.rallyforthecure.org)
6 June 2004
Winter Garden
World Financial Center
New York City
|
Proneuron participated in the special symposium (see below)
|
Rally for the Cure Symposium
(organized by The Spinal Cord
Injury Project, W. M. Keck Center
for Collaborative Neuroscience,
Rutgers, The State University
of New Jersey)
6 June 2004 1-4 p.m.
Embassy Suites Hotel
New York City
|
Announcement of special, cutting-edge research collaboration involving, Kessler Institute for Rehabilitation, The Mount Sinai Medical Center and ProNeuron Biotechnologies.
Details |
Engineered Cellular Products:
Tomorrow's Medicine panel
(Science Track at Bio 2004)
7 June 2004 2:15 p.m.
Room 2016 West
Moscone Center
San Francisco |
Presentation by ProNeuron's CEO, Mr. Nir Nimrodi
|
5th World Stroke Congress
23-26 Jun 2004
Vancouver |
Immune modulator treatment, even 24
hours post ischemic stroke in rats, leads to improved neurological
outcome - abstract |
American Paraplegia
Society Conference
7-9 Sep 2004
Riviera Hotel
Las Vegas |
-
Long-term follow-up
of spinal cord injury patients treated with ProCord (Autologous
Macrophages) -
abstract
-
Characterization of
PROCORD – macrophage cell therapy for Spinal Cord Injury -
abstract
|
7th Intl. Neurotrauma Symposium
12-16 September 2004
Adelaide, Australia |
- The phenotype of activated macrophages associated with spinal
cord repair - abstract
- Long lasting protective effects induced by the immune modulator
PN277 given 24 hours post permanent middle cerebral artery occlusion in
rats - abstract
|
Intl Spinal Cord Soc.
26-29 Sep 2004
Congress Center
Athens, Greece |
-
Accuracy of ASIA Impairment Scale of Spinal
Cord Injury Using the 2002 Standards -
abstract
-
Reliability Levels of the ASIA Motor and
Sensory Examination in Physician versus Physical Therapist Examiners -
abstract
-
Autologous macrophage therapy in patients
with complete spinal cord injuries: Phase I experience -
abstract
|
Congress of Neurological
Surgery
16-21 Oct 2004
Moscone W.
Convention Center
San Francisco |
Immune-based
therapies for Central Nervous System trauma -
abstract |
Natl. Neurotrauma Soc. Symp.
21-22 October 2004
San Diego, California |
Autologous skin-coincubated macrophages, a cell therapy for acute
spinal cord injury: translation of preclinical development for the
clinic - abstract |
Neuroscience 2004
(Society for Neuroscience)
23-27 October 2004
San Diego, California |
Immune modulation: A Novel Treatment for Ischemic Stroke -
abstract |
53rd National Congress
Italian Soc. Neurosurg.
21-24 November 2004
Milan |
Autologous macrophage therapy for patients with complete SCI: Results of
phase I trial and preview on the phase II trial -
abstract |
|
British Assoc. Spinal Cord Injury Specialists
(BASCIS) Meeting
27 January 2005
Cardiff, U.K. |
The ProCord
Experience: A Novel Therapeutic Approach for Acute Complete Spinal Cord
Injury - abstract |
American Physical Therapy Assoc.
(APTA) Combined Sections Meeting
23-27 February 2005
New Orleans |
Presentations:
-
Long term follow-up of spinal cord injury in
the autologous macrophage trial -
abstract
-
The accuracy of motor and sensory scales of
the american spinal injury association standards when assessed by
trained physical therapists and physicians -
abstract
|
Neurodegenerative Drug Development
Forum
Strategies for Drug Development for
Alzheimer's and Parkinson's Disorders
7-8 March 2005
London |
Case Study: Breaking the Degenerative Sequence: Immune Modulation as
an Intervention
Dr. Eti Yoles, VP Product R&D |
California Pacific Rehabilitation
Center
Spinal Cord InjuryConference
"Research, Rehabilitation, Reintegration"
16 April 2005 |
Presentation: Clinical Trials in Spinal Cord Injury |
American Assoc. Neurological Surgeons
(AANS) General Meeting
16-21 April 2005
Ernest Morial Conv. Ctr,
New Orleans |
Booth #727 |
American Spinal Injury Association
(ASIA)
conference
12-14 May 2005
Fairmont Dallas
Hotel
Dallas, Texas |
Instructional Course: "Is a 1970 Quadriplegic the same as a 2004
tetraplegic?" - Details and
synopsis |
13th World Congress of Neurological
Surgery
Marrakesh, Morocco
19 - 24th June 2005 |
Proneuron Biotechnologies special session
on Autologous Macrophage Therapy for Spinal Cord Injury
-
Details and agenda |
23rd Natl. Neurotrauma Soc. Symp.
9-11 November 2005
Washington D.C. |
Macrophage Therapy for Spinal Cord Injury has No Adverse Impact on Function
and Morphology of Spared Nerve Tissue - Abstract |
Neuroscience 2005
35th SFN Annual Meeting
12-16 November 2005
Washington Convention Center
Washington D.C. |
Macrophage Therapy Developed for Complete SCI may also be of benefit for
Incomplete SCI -
Abstract |
